| Literature DB >> 33865409 |
Yi-Bo Yan1, Shuo Shi2, Qian-Biao Wu2, Jin-Sheng Cai1, Bin-Feng Lei3.
Abstract
BACKGROUND: Congenital heart disease is a leading cause of death in newborns and infants. The feasibility of fetal cardiac surgery is linked to extracorporeal circulation (ECC); therefore, cardioplegic solutions need to be effective and long-lasting.Entities:
Keywords: Apoptosis; Congenital heart disease; Creatine kinase–muscle band; Extracorporeal circulation; Fetal sheep; HTK preservation solution (Custodiol®); St Thomas’ Hospital cardioplegic solution; Troponin
Year: 2021 PMID: 33865409 PMCID: PMC8052754 DOI: 10.1186/s13019-021-01486-y
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Major surgical equipment and drugs
| Name | Company | Specification |
|---|---|---|
| Extracorporeal Circulator | STOCKERT,Inc.GER | Shiley |
| Variable temperature water tank | STOCKERT,Inc.GER | 16S093 |
| Multi-parameter monitor | GE,Inc.GER | DragerInfinity Delt |
| Anesthesia machine | BOCGroup,Inc.USA | EXCEL 210 ANS |
| Fentanyl Citrate Injection | HUMANWELL, CHN | 10 mL:0.5 mg |
| Ketamine hydrochloride injection | HUMANWELL, CHN | 2mmL:0.1 g |
| Atropine hydrochloride injection | HUMANWELL, CHN | 1 mL:0.5 g |
| Vecuronium Bromide for Injection | HARBIN MEDISAN PHARMACEUTICAL CO., LTD | 4 mg |
| HTK preservation solution (Custodiol®) | Dr. Franz Koehler Chemie GmnH | 1000 mL |
| St Thomas’ Hospital cardioplegic solution (STH1) | Institute of Cardiovascular Diseases, Guangxi Medical University | 1000 mL |
HTK preservation solution (Custodiol®). Composition. 1000 mL perfusion solution contains
| 0.8766 g | sodium chloride | 15.0 mmol |
| 0.6710 g | potassium chloride | 9.0 mmol |
| 0.8132 g | magnesium chloride·6H2O | 4.0 mmol |
| 3.7733 g | histidine hydrochloride·2H2O | 18.0 mmol |
| 27.9289 g | histidine | 180.0 mmol |
| 0.4085 g | tryptophan | 2.0 mmol |
| 5.4651 g | mannitol | 30.0 mmol |
| 0.0022 g | calcium chloride·2H2O | 0.015 mmol |
| 0.1842 g | potassium hydrogen 2-oxopantendioate | 1.0 mmol |
St Thomas’ Hospital cardioplegic solution (STH1). Composition. 1000 mL perfusion solution contains
| 8.4240 g | sodium chloride | 144.0 mmol |
| 1.4900 g | potassium chloride | 20.0 mmol |
| 1.5200 g | magnesium chloride | 16.0 mmol |
| 0.2664 g | calcium chloride | 2.4 mmol |
| 0.2728 g | procaine hydrochloride | 1.0 mmol |
Comparison of general information and intraoperative condition of the three groups of fetal sheep ( ± s)
| ECC-only group | STH group | HTK group | |
|---|---|---|---|
| Age (d) | 123.71 ± l1.98 | 122.52 ± 12.33 | 130.10 ± 01.23 |
| Weight (kg) | 1.21 ± 0.56 | 1.24 ± 0.47 | 1.33 ± 0.70 |
| cardioplegic solutions perfusion (mL/kg) | – | 47.0 ± 8.4 | 58.0 ± 0.0* |
| Time to return to normal heart rate (s) | – | 45.0 ± 4.3 | 61.0 ± 3.5* |
*P < 0.05, comparison with STH group
Comparison of perioperative hemodynamics in three groups of fetal sheep ( ± s)
| T1 | T2 | T3 | T4 | T5 | |
|---|---|---|---|---|---|
| Heart rates (bpm) | |||||
| ECC-only group | 173.1 ± 20.10 | 169.1 ± 17.18 | 171.7 ± 22.21 | 171.5 ± 18.58 | 178.1 ± 10.12 |
| STH Group | 175.0 ± 15.12 | – | 110.3 ± 22.10* | 177.5 ± 17.14 | 173.2 ± 19.56 |
| HTK Group | 174.6 ± 21.00 | – | 151.1 ± 19.99*# | 174.2 ± 15.11 | 177.8 ± 11.16 |
| Average Arterial Pressure (mmHg) | |||||
| ECC-only group | 57.1 ± 15.67 | 57.3 ± 17.42 | 56.9 ± 19.11 | 57.1 ± 15.12 | 56.5 ± 18.36 |
| STH Group | 56.9 ± 13.81 | 57.5 ± 13.55 | 50.0 ± 16.11* | 59.5 ± 17.22 | 57.1 ± 16.39 |
| HTK Group | 56.9 ± 16.85 | 56.6 ± 17.34 | 58.0 ± 19.73# | 58.2 ± 16.55 | 56.8 ± 15.93 |
| ECC flow rate (mL/kg/min) | |||||
| ECC-only group | – | 101.5 ± 29.22 | – | – | – |
| STH Group | – | 114.9 ± 28.45‡ | – | – | – |
| HTK Group | – | 113.3 ± 29.76‡ | – | – | – |
EC Extracorporeal circulation
T1: Before start of ECC.
T2: 30 min of ECC.
T3: 60 min of ECC.
T4: 60 min after ECC shutdown.
T5: 120 min after ECC shutdown.
* P < 0.05, compared with the pre-ECC; #P < 0.05, compared with the STH group; ‡ P < 0.05, compared with the ECC-only group
Changes in the concentration of cTnI in the three groups. ( ± s)
| Groups | T1 | T2 | T3 | T4 | T5 |
|---|---|---|---|---|---|
| ECC-only group | 59.03 ± 3.21 | 58.23 ± 4.21 | 60.74 ± 2.31 | 65.74 ± 3.25# | 73.43 ± 3.37*# |
| STH Group | 60.21 ± 3.23 | 60.38 ± 5.27 | 61.70 ± 4.51 | 87.52 ± 4.25* ‡ | 90.14 ± 5.96* ‡ |
| HTK Group | 59.01 ± 2.19 | 61.27 ± 3.43 | 65.69 ± 3.24 | 67.17 ± 4.56# | 83.50 ± 4.63* ‡ # |
ECC Extracorporeal circulation
T1: Before start of ECC.
T2: 30 min of ECC.
T3: 60 min of ECC.
T4: 60 min after ECC shutdown.
T5: 120 min after ECC shutdown.
* P < 0.05, compared with the pre-ECC; #P < 0.05, compared with the STH group; ‡ P < 0.05, compared with the ECC-only group
Changes in the concentration of cTnT in the three groups (± s)
| Groups | T1 | T2 | T3 | T4 | T5 |
|---|---|---|---|---|---|
| ECC-only group | 101.83 ± 12.54 | 100.11 ± 10.31 | 104.27 ± 12.11 | 105.44 ± 9.40 # | 119.85 ± 11.07*# |
| STH Group | 103.57 ± 16.32 | 103.49 ± 10.12 | 105.96 ± 17.28 | 117.31 ± 7.75*‡ | 136.41 ± 9.02*‡ |
| HTK Group | 99.40 ± 13.53 | 103.78 ± 14.56 | 107.93 ± 10.85 | 110.62 ± 9.54 | 129.69 ± 8.90*# |
ECC Extracorporeal circulation
T1: Before start of ECC.
T2: 30 min of ECC.
T3: 60 min of ECC.
T4: 60 min after ECC shutdown.
T5: 120 min after ECC shutdown.
* P < 0.05, compared with the pre-ECC basis; # P < 0.05, compared with the STH group; ‡ P < 0.05, compared with the ECC-only group
Changes in the concentration of CKMB in the three groups (± s)
| Groups | T1 | T2 | T3 | T4 | T5 |
|---|---|---|---|---|---|
| ECC-only group | 0.51 ± 0.01 | 0.51 ± 0.02 | 0.55 ± 0.01 | 0.56 ± 0.01 | 0.59 ± 0.02 |
| STH Group | 0.50 ± 0.04 | 0.50 ± 0.08 | 0.54 ± 0.08 | 0.55 ± 0.02 | 0.66 ± 0.03* ‡ |
| HTK Group | 0.53 ± 0.01 | 0.53 ± 0.04 | 0.53 ± 0.07 | 0.54 ± 0.03 | 0.64 ± 0.06* ‡ # |
ECC Extracorporeal circulation
T1: Before start of ECC.
T2: 30 min of ECC.
T3: 60 min of ECC.
T4: 60 min after ECC shutdown.
T5: 120 min after ECC shutdown.
* P < 0.05, compared with the pre-ECC basis; # P < 0.05, compared with the STH group; ‡ P < 0.05, compared with the ECC-only group
Fig. 2The concentration of cTnI in the three different groups. Note: * P < 0.05, compared with the pre-ECC basis; # P < 0.05, compared with the STH group; ‡ P < 0.05, compared with the ECC-only group
Fig. 3The concentration of cTnT in three different groups. Note: * P < 0.05, compared with the pre-ECC basis; # P < 0.05, compared with the STH group; ‡ P < 0.05, compared with the ECC-only group
Fig. 4The concentration of CKMB in three different group. * P < 0.05, compared with the pre-ECC basis; # P < 0.05, compared with the STH group; ‡ P < 0.05, compared with the ECC-only group
Fig. 5TUNEL assay to detect cell apoptosis (400×). Note: a Apoptosis of cardiomyocytes after ECC in the ECC-only group. b Apoptosis of cardiomyocytes after ECC in the HTK group. c Apoptosis of cardiomyocytes after ECC in the STH group. d Comparison of the apoptotic index of the three groups, *P < 0.05 compared with the ECC-only group; #P < 0.05 compared with the HTK group